Also affiliated with Piedmont Cancer Institute
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 6 papers. Top paper: “Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial”.
L.D. Eli, Hans Wildiers, Sara A. Hurvitz, Ángel Guerrero‐Zotano, Nisha Unni +37 more
Ismaheel O. Lawal, Saima Muzahir, Sarah Friend, Manali Bhave, Jane Meisel +8 more
Leslie Nehring, J. L. Anderson, Brittney Haas, Jingqin Luo, Meghna S. Trivedi +10 more
Jolinta Y. Lin, Manali Bhave, Gabrielle Brown, India Green, Xiaofeng Yang +4 more
Thomas Hu, Jeongjin Lee, Jeffrey Aldrich, Sunil Badve, Yesim Gökmen‐Polar +5 more
Princess Ekpo, Manali Rupji, Jeffrey M. Switchenko, Mylin A. Torres, Kevin Kalinsky +2 more